Pharmaceutical Inspection Machines Market worth $1.62 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., June 11, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Pharmaceutical Inspection Machines Market is projected to grow from about USD 1.14 billion in 2026 to USD 1.62 billion by 2031, at a CAGR of 7.2%.

Browse 200 market data Tables and 100 Figures spread through 300 Pages and in-depth TOC on "Pharmaceutical Inspection Machines Market - Global Forecast to 2031"

Pharmaceutical Inspection Machines Market Size & Forecast:

• Market Size Available for Years: 2025–2031
• 2026 Market Size: USD 1.14 billion
• 2031 Projected Market Size: USD 1.62 billion
• CAGR (2026–2031): 7.2%

Pharmaceutical Inspection Machines Market Trends & Insights:

• The conventional pharmaceutical inspection machine is estimated to lead the market, accounting for a share of 93.0% in 2026.
• Fully automated machines are expected to record a higher CAGR during forecast period.
• Ampoules & vials are projected to record a higher CAGR during the forecast period.
• India is set to register the highest CAGR of 8.6% during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085

Global pharmaceutical production is increasing significantly due to rising healthcare needs, aging populations, chronic disease prevalence, and expanding access to medicines. Growth in generic drugs, over-the-counter products, vaccines, and specialty therapeutics has substantially increased manufacturing volumes. As production output expands, manufacturers require efficient systems capable of inspecting large quantities of products without compromising quality. Manual inspection processes become difficult, time-consuming, and less reliable at high production scales. Pharmaceutical inspection machines support large-scale operations by providing rapid and consistent quality checks, reducing bottlenecks, minimizing product defects, and ensuring that increasing production demands are met while maintaining regulatory and quality standards.

Inspection systems accounted for the largest share of the pharmaceutical inspection machines market by component in 2025.

The widespread adoption of inspection systems across pharmaceutical manufacturing facilities significantly contributes to their leading market share. Pharmaceutical manufacturers increasingly prioritize automated quality assurance, regulatory compliance, and production efficiency, driving demand for advanced inspection systems over standalone software solutions. Inspection systems integrated with machine vision, AI-powered analytics, X-ray technologies, checkweighers, sensors, and robotics enable high-speed and precise detection of defects, contamination, fill-level inconsistencies, and packaging errors. These systems are extensively deployed for inspecting vials, syringes, ampoules, cartridges, and various packaging formats with greater speed and accuracy than traditional methods. Additionally, continuing production of injectable drugs, biologics, and complex pharmaceutical formulations continues to accelerate demand for sophisticated inspection systems capable of ensuring product integrity, minimizing recalls, and maintaining stringent quality standards.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=81453085

Pharmaceutical companies accounted for the largest share of the pharmaceutical inspection machines market by end user in 2025.

The dominant share of pharmaceutical companies is driven by their extensive adoption of inspection machines to maintain product quality, ensure regulatory compliance, and support high-volume manufacturing operations. Pharmaceutical manufacturers increasingly rely on automated inspection systems equipped with AI, machine vision, X-ray technologies, and advanced sensors to detect defects and ensure product integrity across vials, syringes, ampoules, cartridges, and packaging formats. Rising production of biologics, injectables, and specialty drugs, along with stringent quality requirements from regulatory authorities, continues to increase demand for advanced inspection solutions. Furthermore, growing investments in smart manufacturing and process automation have strengthened the adoption of pharmaceutical inspection machines among pharmaceutical companies, supporting their leading market position.

Asia Pacific is expected to exhibit the highest growth rate in the pharmaceutical inspection machines market during the forecast period.

Asia Pacific is witnessing rapid expansion in pharmaceutical manufacturing, particularly in countries such as China, India, Japan, and South Korea, which collectively contribute a substantial share of global pharmaceutical production. The region is experiencing increasing demand for generic drugs, biologics, vaccines, and injectable products, creating strong demand for advanced pharmaceutical inspection technologies. Additionally, rising healthcare expenditure and expanding pharmaceutical infrastructure are supporting the modernization of manufacturing facilities. Governments and regulatory agencies are increasingly emphasizing quality standards, product safety, and compliance with international manufacturing regulations. Growing investments in automation and the adoption of Industry 4.0 technologies are further accelerating the deployment of advanced inspection systems. As pharmaceutical manufacturers expand production capacity and strengthen quality assurance practices, demand for inspection machines continues to rise. This continuously expanding manufacturing ecosystem serves as a major factor supporting the region's high CAGR during the forecast period.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=81453085

Top Companies in Pharmaceutical Inspection Machines Market:

The Top Companies in Pharmaceutical Inspection Machines Market include Körber AG (Germany), Mettler Toledo (US), Omron Corporation (Japan), Cognex Corporation (US), Stevanato Group (Italy), Antares Vision S.p.A. (Italy), Optel Group (Canada), Syntegon Technology GmbH (Germany), Jekson Vision (India), ACG (India), Brevetti CEA S.p.A. (Italy), Roquette Frères (France), Toflon Life Science (China), Prodieco (Ireland), WIPOTEC GmbH (Germany), and CMP Pharma S.R.L. (Italy).

Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting

Related Reports:

Pharmaceutical Packaging Equipment Market - Global Forecast to 2030

Pharmaceutical Drying Equipment Market - Global Forecast to 2029

Empty Capsules Market - Global Forecast to 2030  

Pharmaceutical Excipients Market - Global Forecast to 2030

X-Ray Detectors Market - Global Forecast to 2031

About MarketsandMarkets™ 

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/